-
Lux Cozi Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
No Comments
Get the complete Lux Cozi Q4 Results 2026 preview including expected date, revenue estimate of Rs 118 Cr, PAT estimate of Rs 21 Cr and latest analyst ratings. Updated on Univest.
-
SecUR Credentials Q4 Results FY26 Background Verification Business Grows on India GCC Expansion
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
SecUR Credentials Q4 results FY26 declared May 4. Background verification and credential validation business benefits from India GCC expansion, compliance requirements, and employment formalisation.
-
Bandhan Bank Share Price Target 2026: Analyst Forecast, Growth Catalysts and Key Risks
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
Bandhan Bank share price target 2026 is Rs 200. Analyst forecast, bull case Rs 260, bear case Rs 110. Catalysts, risks and full analysis. April 2026.
-
LIC Housing Finance Share Price Target 2026: Analyst Forecast, Growth Catalysts and Key Risks
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
LIC Housing Finance share price target 2026 is Rs 750. Analyst forecast, bull case Rs 950, bear case Rs 450. Catalysts, risks and full analysis. April 2026.
-
Alkem Laboratories Share Price Target 2026: Analyst Forecast, Growth Catalysts and Key Risks
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
Alkem Laboratories share price target 2026 is Rs 6,500. Analyst forecast, bull case Rs 8,200, bear case Rs 4,000. Catalysts, risks and full analysis. April 2…
-
Union Bank of India Share Price Target 2026: Analyst Forecast, Growth Catalysts and Key Risks
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
Union Bank of India share price target 2026 is Rs 145. Analyst forecast, bull case Rs 185, bear case Rs 85. Catalysts, risks and full analysis. April 2026.
-
Marksans Pharma Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
Get the complete Marksans Pharma Q4 Results 2026 preview including expected date, revenue estimate of Rs 648 Cr, PAT estimate of Rs 105 Cr and latest analyst ratings. Updated on Univest.
-
Medanta (Global Health) Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- May 5, 2026
- Posted by: Harsh Piplani
- Category: News
Get the complete Medanta (Global Health) Q4 Results 2026 preview including expected date, revenue estimate of Rs 972 Cr, PAT estimate of Rs 138 Cr and latest analyst ratings. Updated on Univest.
-
Lloyds Luxuries Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
Get the complete Lloyds Luxuries Q4 Results 2026 preview including expected date, revenue estimate of Rs 58 Cr, PAT estimate of Rs 5 Cr and latest analyst ratings. Updated on Univest.
-
Linde India Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- May 5, 2026
- Posted by: Neeraj Pandey
- Category: News
Get the complete Linde India Q4 Results 2026 preview including expected date, revenue estimate of Rs 838 Cr, PAT estimate of Rs 198 Cr and latest analyst ratings. Updated on Univest.